Onkologie / Hämatologie -

Zentrum Innere Medizin Schwerpunkt Onkologie, Hamburg, Prof. Dr. med. Udo Vanhoefer

Prof. Dr. med. Udo Vanhoefer - Onkologie / Hämatologie, Hamburg - Publikationen

Sabine Beck, Andreas van de Loo, Stelle Reiter-Theil
A "little bit illegal"? Withholding and withdrawing of mechanical ventilation in the eyes of German intensive care physicians. Med Health Care and Philos (22008) 11:7-16, DOI 10.1007/s11019-007-9097-8

Thiesemann R., Hannemann-Pohl K., Becker H., Buenemann H., Gerigk C.
Urinary tract infections: contaminated specimens, limitations of urinalysis and 2-year resistance changes in 4,515 consecutive urine cultures, European Journal of Geriatrics; Vol. 8 (2006) No. 1.

Van de Loo, A., Nieblung. W.
Aktuelle kardiologische Pharmakotherapie, (Current Cardiological Pharmacotherapy) ... Z Allg Med 2006; 82: 124 - 128

Vanhoefer, U.
Irinotecan in combination with new agents. (2004)

Vanhoefer U., Tewes M., Rojo F., Dirsch O., Schleucher N., Rosen O., Tillner J., Kovar A., Braun A.H., Trarbach T., Seeber S., Harstrick A., Baselga J.
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor. J Clin Oncol. 2004 Jan 1;22(1):175-84.

Vanhoefer U.
Novel molecular approaches in the therapy of advanced colorectal carcinoma. Onkologie. 2003 Dec; 26 Suppl 7:70-4.

Vanhoefer U., Rougier P., Wilke H., Ducreux M.P., Lacave A.J., Van Cutsem E., Planker M., Santos J.G., Piedbois P., Paillot B., Bodenstein H., Schmoll H.J., Bleiberg H., Nordlinger B., Couvreur M.L., Baron B., Wils J.A.
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol. 2000 Jul;18(14):2648-57.

Wilke H., Stahl M., Vanhoefer U.
Patient with stomach cancer with metastases. What is the value of chemotherapy? MMW Fortschr Med. 2003 Nov 27;145(48):39-42.

Thomas AL, Trarbach T, Bartel C, Laurent D, Henry A, Poethig M, Wang J, Masson E, Steward W, Vanhoefer U, Wiedenmann B.: A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer. Ann Oncol. 2007 Apr;18(4):782-8. Epub 2007 Jan 11. PMID: 17218488

Vanhoefer U.:
Molecular mechanisms and targeting of colorectal cancer. Semin Oncol. 2005 Dec;32(6 Suppl 8):7-10. Review. PMID: 16360005

Braun AH, Stark K, Dirsch O, Hilger RA, Seeber S, Vanhoefer U.:
The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan.Braun AH, Stark K, Dirsch O, Hilger RA, Seeber S, Vanhoefer U. Anticancer Drugs. 2005 Nov;16(10):1099-108. PMID: 16222152